NCT06692140View on ClinicalTrials.gov

Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated with Percutaneous Coronary Intervention

NARecruitingINTERVENTIONAL
Enrollment

3,150

Participants

Timeline

Start Date

November 16, 2024

Primary Completion Date

July 1, 2028

Study Completion Date

July 1, 2032

Conditions
Ischemia, MyocardialCoronary Artery DiseasePercutaneous Coronary Intervention (PCI)
Interventions
DEVICE

Ultra-low strut thickness everolimus-eluting biodegradable polymer Evermine50 stent(s)

Percutaneous coronary intervention with Ultra-low strut thickness everolimus-eluting biodegradable polymer Evermine50 stent(s)

DEVICE

PCI with Everolimus-eluting stents (durable polymer everolimus-eluting Xience or Promus stent(s))

Percutaneous coronary intervention with Everolimus-eluting stents (durable polymer everolimus-eluting Xience or Promus stent(s))

Trial Locations (3)

5000

RECRUITING

Odense University Hospital, Odense

8200

RECRUITING

Aarhus University Hospital, Aarhus

9000

RECRUITING

Aalborg University Hospital, Aalborg

All Listed Sponsors
lead

Odense University Hospital

OTHER